2 results
Approved WMOCompleted
Primary:* To assess the safety and tolerability of LAM-001 administered daily by dry powder inhaler (DPI) for 14 days in patients with lymphangioleiomyomatosis (LAM) (Period 1).* To assess the longer-term safety and tolerability of LAM-001…
Approved WMOCompleted
The objective of the study is to evaluate the performance and efficiency of the AcQMap Imaging and Mapping System in an ablation retreatment procedure for recurrent atrial fibrillation following a failed AF ablation